Apoptosis: Its pathophysiology and monitoring. The role of apoptosis in the radioiodine therapy of hyperthyroidism

Nuclear Medicine Review

Volumn 7, Issue 1, 2004, Pages 53-58

  Sopotyk, Antoni J ^a   Rogowski, Franciszek ^a   Parfieńczyk, Adam ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; Radioiodine (I 131); Thyroid

Indexed keywords

ANTINEOPLASTIC AGENT; BIOTIN; FLUORESCEIN ISOTHIOCYANATE; IODINE 131; LIPOCORTIN 5; MYOSIN ANTIBODY IN 111; PHOSPHATIDYLSERINE; RADIOACTIVE IODINE; RADIOISOTOPE; SACCHARIC ACID; TECHNETIUM 99M; TRACER;

APOPTOSIS; BETA RADIATION; BINDING AFFINITY; CELL DESTRUCTION; DRUG HALF LIFE; DRUG INDICATION; DRUG SAFETY; DRUG UPTAKE; GAMMA RADIATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMAGING SYSTEM; MEDICAL RESEARCH; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; PATIENT MONITORING; REVIEW; THYROID CANCER; THYROID CELL; THYROID GLAND; TISSUE INJURY;

ANIMALS; APOPTOSIS; CELL SURVIVAL; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; RADIOPHARMACEUTICALS; THYROID GLAND;

EID: 2942574453     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Peter ME, Heufelder AE, Hengartner MO. Advances in apoptosis research. Proc Natl Acad Sci 1997; 24: 12736-12737.
2. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
3. Hetts SW. To die or not to die: an overview of apoptosis and its role in disease. JAMA 1998; 279: 300-307.
4. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM, Venkatachalam MA. Apoptosis: definition, mechanisms, and relevance to disease. Am J Med 1999; 107: 489-506.
5. Van Cruchten S, Van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol 2002; 31: 214-223.
6. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-1449.
7. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-1308.
8. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003; 348: 1365-1375.
9. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000; 407: 802-809.
10. Kang PM, Izumo S. Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases Trends Mol Med 2003; 9: 177-182.
11. Kanuka H, Hisahara S, Sawamoto K, Shoji S, Okano H, Miura M. Proapoptotic activity of Caenorhabditis elegans CED-4 protein in Drosophila: Implicated mechanisms for caspase activation PNAS 1999; 96: 145-150.
12. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776.
13. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365.
14. Raff M. Cell suicide for beginners. Nature 1998; 396: 119-122.
15. Sinkovics J, Horvath J, Savitz S, Hetts S. Role of apoptosis in health and disease. JAMA 1998; 279: 1699-1700.
16. Younes A, Kadin ME. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy. J Clin Oncol 2003; 21: 3526-3534.
17. Ahmad M, Shi Y. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention. Oncogene 2000; 19: 3363-3371.
18. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33-42.
19. Jurgensmeier JM, Xie Z, Deveraux Q et al. Bax directly induces release of cytochrome c from isolated mitochondria PNAS 1998; 95: 4997-5002.
20. Demaurex N, Distelhorst C. Cell biology. Apoptosis-the calcium connection. Science 2003; 300: 65-67.
21. Nutt LK, Pataer A, Pahler J et al. Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca2+ stores. J Biol Chem 2002; 277: 9219-9225.
22. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000; 407: 802-809.
23. Brauer M. In vivo monitoring of apoptosis. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 323-331.
24. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003; 348: 1365-1375.
25. Blankenberg FG, Loh NN, Bracci P et al. Sonography, CT, and MR imaging: a prospective comparison of neonates with suspected intracranial ischemia and hemorrhage. Am J Neuroradiol 2000; 21: 213-218.
26. D'Arceuil H, Rhine W, de Crespigny A et al. 99mTc annexin V imaging of neonatal hypoxic brain injury. Stroke 2000; 31: 2692-2700.
27. Love S. Apoptosis and brain ischaemia. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 267-282.
28. Bennett MR. Apoptosis in the cardiovascular system. Heart 2002; 87: 480-487.
29. Hofstra L, Liem IH, Dumont EA et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000; 356: 209-212.
30. Blankenberg FG, Tait JF, Strauss HW. Apoptotic cell death: its implications for imaging in the next millennium. Eur J Nucl Med 2000; 27: 359-367.
31. Mitsiades N, Poulaki V, Kotoula V et al. Fas/Fas ligand up-regulation and BCL-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. J Clin Endocrinol Metab 1998; 83: 2199-2203.
32. Hussein MR, Haemel AK, Wood GS. Apoptosis and melanoma: molecular mechanisms. J Pathol 2003; 199: 275-288.
33. Salmaso C, Bagnasco M, Pesce G et al. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. Ann NY Acad Sci 2002; 966: 496-501.
34. Kabelitz D. Apoptosis, graft rejection, and transplantation tolerance. Transplantation 1998; 65: 869-875.
35. Blankenberg FG, Strauss HW. Non-invasive diagnosis of acute heart- or lung-transplant rejection using radiolabeled annexin V. Pediatr Radiol 1999; 29: 299-305.
36. Zheleva DI, Lane DP, Fischer PM. The p53-Mdm2 pathway: targets for the development of new anticancer therapeutics. Mini Rev Med Chem 2003; 3: 257-270.
37. Schueneman AJ, Himmelfarb E, Geng L et al. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. Cancer Res 2003; 63: 4009-4016.
38. Wang CY, Zhong WB, Chang TC, Lai SM, Tsai YF. Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells. J Clin Endocrinol Metab 2003; 88: 3021-3026.
39. Schellenberger EA, Bogdanov A Jr, Petrovsky A, Ntziachristos V, Weissleder R, Josephson L. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia 2003; 5: 187-192.
40. Subbarayan M, Hafeli UO, Feyes DK, Unnithan J, Emancipator SN, Mukhtar H. A simplified method for preparation of 99mTc-annexin V and it's biological evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med 2003; 44: 650-656.
41. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
42. Kelly KJ, Sandoval RM. A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosis. Am J Physiol Cell Physiol 2003; 284.
43. Mirakian R, Nye K, Palazzo FF, Goode AW, Hammond LJ. Methods for detecting apoptosis in thyroid diseases. J Immunol Methods 2002; 265: 161-175.
44. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-1132.
45. Narula J, Strauss HW. Invited commentary: P.S.* I love you: implications of phosphatidyl serine (PS) reversal in acute ischemic syndromes. J Nucl. Med 2003; 44: 397-399.
46. Flotats A, Carrio I. Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med Mol Imag 2003; 30: 615-630.
47. Khaw BA, Silva JD, Petrov A, Hartner W. Indium 111 antimyosin and Tc-99m glucaric acid for noninvasive identification of oncotic and apoptotic myocardial necrosis. J Nucl Cardiol 2002; 9: 471-481.
48. Stratton JR, Dewhurst TA, Kasina S et al. Selective uptake of radiolabelled annexin V on acute porcine left atrial thrombi. Circulation 1995; 92: 3113-3121.
49. Blankenberg FG, Naumovski L, Tait JF, Post AM, Strauss HW. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V. J Nucl Med 2001; 42: 309-316.
50. Mochizuki T, Kuge Y, Zhao S et al. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V. J Nucl Med 2003; 44: 92-97.
51. Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A Jr. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 2003; 63: 1936-1942.
52. Lahorte C, Slegers G, Philippe J, Van de Wiele C, Dierckx RA. Synthesis and in vitro evaluation of 123I-labelled human recombinant annexin V. Biomol Eng 2001; 17: 51-53.
53. Glaser M, Collingridge DR, Aboagye EO et al. Iodine-124 labelled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography. Appl Radiat Isot 2003; 58: 55-62.
54. Zijlstra S, Gunawan J, Burchert W et al. Synthesis and evaluation of an 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl Radiat Isot 2003; 58 (2): 201-207.
55. Kotani T, Aratake Y, Hirai K, Fukazawa Y, Sato H, Ohtaki S. Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity 1995; 20: 231-236.
56. Hammond LJ, Palazzo FF, Shattock M, Goode AW, Mirakian R. Thyrocyte targets and effectors of autoimmunity: a role for death receptors? Thyroid 2001; 11: 919-927.
57. Lumachi F, Basso S. Apoptosis: life through planned cellular death regulating mechanisms, control systems, and relations with thyroid diseases. Thyroid 2002; 12: 27-34.
58. Mitsiades CS, Poulaki V, Mitsiades N. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer. J Endocrinol 2003; 178: 205-216.
59. Shinomiya N. New concepts in radiation-induced apoptosis: "premitotic apoptosis" and "postmitotic apoptosis". J Cell Mol Med 2001; 5: 240-253.
60. Cooper DS. Radioiodine for hyperthyroidism: Where do we stand after 50 years? JAMA 1998; 280: 375-376.
61. Parfieńczyk A, Rogowski F, Budlewski T, Jurgilewicz D, Sopotyk A, Szumowski P, Kiersnowska-Rogowska B. Effect of I-131 therapy on concentration of apoptotic markers in the blood of patients with toxic multinodular goitre (TMG). Preliminary report. Eur J Nucl Med Mol Imag 2003; 30: 163-163.